Evidence map›Paper›PMID 40314213›Full record

SynthesisEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2025

Multiparametric models for predicting major arrhythmic events in Brugada syndrome: a systematic review and critical appraisal.

Daniel A Gomes, Pier D Lambiase, Richard J Schilling, Riccardo Cappato, Pedro Adragão, Rui Providência

Abstract readSystematic Review
In one paragraph

Synthesis in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Long-term predictors of outcome in Brugada syndrome patients after implantable cardioverter-defibrillator implant.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  2. Review
  3. A heart job: predicting sudden cardiac arrest.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  4. Review
  5. Brugada syndrome risk scores: what we've learned and what's next.Frontiers in cardiovascular medicine · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Daniel A GomesDepartment of Cardiology, Hospital de Santa Cruz, Lisbon, Portugal.ORCID 0000-0002-6894-648X
Pier D LambiaseInstitute of Cardiovascular Science, University College London, London, UK.ORCID 0000-0002-9055-9267
Richard J SchillingBarts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.ORCID 0000-0002-0621-8241
Riccardo CappatoArrhythmia and Clinical Electrophysiology Center, IRCCS, MultiMedica, Milan, Italy.ORCID 0000-0003-0615-9525
Pedro AdragãoDepartment of Cardiology, Hospital de Santa Cruz, Lisbon, Portugal.ORCID 0000-0003-3729-3137
Rui ProvidênciaBarts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.ORCID 0000-0001-9141-9883

Funding

NIHR NIHR129463NIHR UKRI/ERC/HORIZON 10103153UCL BHF Research Accelerator AA/18/6/34223
6 · The paper itself

Abstract

aimsDespite several risk models to predict major arrhythmic events (MAE) in Brugada syndrome (BrS) having been developed, reproducibility and methodology remain a concern. Our aim was to assess the quality of model development and validation, and determine the discriminative performance of available models. METHODS AND

resultsElectronic databases (Medline, Embase, and Central) were searched through September/2024 for studies developing or validating multivariable prediction models for MAE in BrS. Methodological quality and risk of bias (RoB) were assessed using the Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies (CHARMS) checklist and the Prediction Model Risk of Bias Assessment (PROBAST) Tool. Pooled random-effects c-statistics were obtained for each model. A total of 16 studies, including 11 unique multivariable scores, were included. All models had domains classified as high RoB. Common sources of bias were inappropriate inclusion/exclusion criteria, predictor selection, low number of events and underreporting of performance measures. Pooled c-statistics among patients without previous MAE showed good performance for Brugada-Risk [AUC 0.81, 95% confidence interval (CI) 0.71-0.91; I2 64%; three studies], fair for PAT (AUC 0.79, 95% CI 0.45-1.12; I2 95%; two studies), Delise (AUC 0.77, 95% CI 0.72-0.81, I2 39%, three studies), and Sieira (AUC 0.73, 95% CI 0.64-0.82; I2 64%; five studies), and moderate for Shanghai (AUC 0.69, 95% CI 0.61-0,76; I2 13%; three studies).

conclusionCurrently available multiparametric models for prediction of MAE in BrS have important shortcomings in model development and inadequate evaluation. Further validation of current models in external cohorts is required before safe transition to clinical practice.

Indexed as

Brugada SyndromeHumansReproducibility of ResultsRisk AssessmentRisk FactorsBrugada syndromeMethodsPROBASTRisk scoresSudden cardiac deathVentricular arrhythmia

Identifiers

PMID40314213
PMCPMC12092914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.